 |
 |

Step-Down Therapy in HypertensionImportance in Long-term Management
Frank A. Finnerty, Jr, MD
JAMA. 1981;246(22):2593-2596.
Abstract
To determine the minimum amount of therapy needed to control arterial pressure, the amount of one drug was reduced, then use of one or more drugs was discontinued after the diastolic pressure had been lower than 90 mm Hg for six months in 51 hypertensive patients. By six months, one drug had been eliminated in 38 patients, and the dose of another had been decreased in 49 patients. By 12 months, stepping up therapy was necessary in 13 patients; thus, one drug therapy had been eliminated in only 27 patients, and the dose was decreased in another 43 patients. No further therapeutic changes were necessary during the next six months. Originally, 161 complaints of side effects were noted. After step-down therapy, 18% of the side effects were reported unchanged, 26% were significantly decreased, and 56% were completely absent.
(JAMA 1981;246:2593-2596)
Author Affiliations
From the Department of Medicine, George Washington University Medical School, and The Hypertension Center of Washington, DC.
Footnotes
Reprint requests to The Hypertension Center of Washington, DC, 1341 Pennsylvania Ave SE, Washington, DC 20003 (Dr Finnerty).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure
Little et al.
BMJ 2002;325:254-254.
ABSTRACT
| FULL TEXT
Effect of Administration and Withdrawal of Doxazosin on Ambulatory Blood Pressure in Patients with Essential Hypertension
Takata et al.
ANGIOLOGY 1995;46:11-18.
ABSTRACT
Doxazosin Withdrawal and Ambulatory Blood Pressure Monitoring in Normotensive Subjects
Takata et al.
ANGIOLOGY 1994;45:17-23.
ABSTRACT
Remission of Hypertension: The 'Natural' History of Blood Pressure Treatment in the Framingham Study
Dannenberg and Kannel
JAMA 1987;257:1477-1483.
ABSTRACT
|